CITRO PHARM setting a manufacturing facility in south east asia and Middle east and it’s spread over an area of 7000 sq. meters. GMP manufacturing facility to support our commercial launches, The facility utilizes the latest single-use technologies from vial to vial by having ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and experienced workforce. It makes us comparable to any Multinational Company and eligible for any international inspection.
CITRO PHARM will be building a state of the art Sterile Containment facility to manufacture Injectable, oncology, biosimilars and vaccines. In addition to the oncology facility, it is involved in the Technology, Manufacture, and Marketing of Specialized Therapeutic molecules.
Its initial vision is to cater the third world Market and then register MENA, CIS and EMEA markets through partnering companies and associates.
CITRO focused to build the quality of the facility to match with all critical requirements of FDA/EMEA regulations.
The manufacturing facility has State-of-the-Art machinery to manufacture both Liquid and Lyophilized products.
Some other features of our facility:
- Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
- Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
- Fully automated with electronically controlled operating system as per GAMP-4 (Good Automated Manufacturing Practice) guidelines.
- Sophisticated Effluent Treatment Plant (ETP)
- Conforms to international environmental, health & safety regulations.
The Facility Highlights include:
- State of the art cGMP Facility
- 7,000 sq. meters. facility with HVAC system
- Vial to vial single-use technology and closed processing
- lean steam, process chiller, central CIP, or WFI generation in design
- German Company filler with RABS technology
- Fill volume from 2.0 to 100ml with IPC
- Lypholizer with 7.5M3
- Equipment and Instruments are SCADA 21-CFR Compliant
- Facility Access using Siemens Bio-Metric Control and Building management System
- Environmental Monitoring using Continuous SMA and PMS systems.
- MENA/ASIA Marketing and Sales
- Contract Filling Available.
Manufacturing facility will be regularly inspected to ensure that they are and remain cGMP (current Good Manufacturing Practice) compliant, while marketed products are regularly monitored to ensure continuous quality standards.
MANUFACTURING PHARMA FACILITY:
CITRO Pharm product are produced at world class manufacturing facilities comply with standards stipulated by International Regulatory bodies. The facility has been validated through successful inspections by the UK MHRA, AUSTRALIA TGA, PICS, MCC SOUTH AFRICA, CANADA HEALTH resulting in cGMP compliance / certification / accreditations by these regulatory bodies. We largely export to Semi regulated and non regulated markets such south east asia, latin America, Africa, MENA region and other world market.State-of-the-art manufacturing facilities, where an independent quality control department unit is been maintained. The manufacturing unit includes manufacturing facilities of tablet, capsules, liquids and dry syrups (dry powder) at Palghar and small volume parentals (Vials, Ampoules, Lyophilized Vials), Eye/Ear/Nasal Drops, Liquid Orals external products at Tarapur plant. Competent, experienced, motivated Pharma control staff manages the CITRO PHARM Operation.
